
TAK Technical Analysis Summary (NYSE)
Analyze TAK on the NYSE with RSI, MACD, ADX, Bollinger Bands, support, resistance, momentum, and the latest technical trading signals.
Disclaimer for Technical Analysis Page
The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full DisclaimerTAK Technical Analysis Summary (NYSE)
Takeda Pharmaceutical Company Limited (NYSE: TAK) stock currently shows a bullish trend on the NYSE, supported by momentum and strong buying pressure.
Technical conditions suggest Takeda Pharmaceutical Company Limited on the NYSE is awaiting a decisive move. Overall, Takeda Pharmaceutical Company Limited remains neutral, with indicators showing mixed momentum.
RSI (14): 58.35
Stochastic %K: 77.23
Williams %R: -27.12
Rate of Change (ROC): 3.54
Takeaway:Takeda Pharmaceutical Company Limited shows strong bullish momentum, with buyers firmly in control.
MACD: 0.22
ADX: 20.03
ATR (14): 0.34
CCI (14): 38.13
Takeaway:Takeda Pharmaceutical Company Limited shows a firm trend supported by momentum, though one signal suggests caution.
Takeaway:Takeda Pharmaceutical Company Limited trades closer to resistance, supported by stronger momentum within bands.
Takeaway:Takeda Pharmaceutical Company Limited trades above the trend line, showing healthy momentum within the channel.
Overall Takeaway:TAK shows bullish money flow, with volume and vigor supporting buyers.
Bullish Signals
RSI above 50 → positive momentum from buyers.
MACD above 0 → bullish trend confirmation.
ADX above 20 → strong underlying trend.
Price trading above middle Bollinger Band → mid-term support intact.
MFI below 80 → room for more buying without overbought risk.
Bearish Signals
No significant bearish signals detected.
Overall Recommendation:Takeda Pharmaceutical Company Limited stock shows a Strong Buy signal — momentum and trend strength are firmly positive, supported by stable volatility.